These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 352706)

  • 21. Effects of molsidomine on global and regional left ventricular function at rest and during exercise in patients with angina pectoris.
    Nechwatal W; Stauch M; Sigel H; Kress P; Bitter F; Geffers H; Adam WE
    Clin Cardiol; 1981; 4(5):248-53. PubMed ID: 6895491
    [No Abstract]   [Full Text] [Related]  

  • 22. [Comparative examinations of the effectiveness of Molsidomin and nitrates in angina pectoris].
    Lehmann HU; Ziegler G; Hochrein H
    Med Welt; 1980 Jul; 31(29-30):1099-103. PubMed ID: 6774198
    [No Abstract]   [Full Text] [Related]  

  • 23. [The effect of molsidomin on the arterial windkessel (author's transl)].
    Sauer G; Tebbe U; Krause H; Kreuzer H; Neuhaus KL
    Z Kardiol; 1981 Sep; 70(9):713-8. PubMed ID: 6895435
    [TBL] [Abstract][Full Text] [Related]  

  • 24. [Effect duration and dose-response relation of molsidomine in patients with coronary heart disease].
    Fach WA; Becker HJ
    Z Kardiol; 1984 Oct; 73(10):613-22. PubMed ID: 6393621
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Anti-ischemic effect of 8 mg molsidomin in retard form].
    Blasini R; Brügmann U; Rudolph W
    Herz; 1984 Dec; 9(6):346-52. PubMed ID: 6392050
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effects of molsidomine on exercise tolerance in patients with coronary heart disease.
    Messin R; Demaret B; Denolin H
    Int J Cardiol; 1983 May; 3(2):137-44. PubMed ID: 6688064
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Exercise tolerance in coronary patients: randomized trial of two-week treatment with molsidomine versus placebo.
    Messin R
    Am Heart J; 1985 Mar; 109(3 Pt 2):667-9. PubMed ID: 3883732
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Treatment of angina pectoris with molsidomin: results of a double-blind study for assessment of rate of anginal attacks, exercise reaction, and systolic time intervals (author's transl)].
    Mannes GA; Goebel G; Kafka W; Rudolph W
    Herz; 1978 Jun; 3(3):172-84. PubMed ID: 363584
    [No Abstract]   [Full Text] [Related]  

  • 29. [Comparative study of the anti-angina drug korvatone (molsidomin) and organic nitrates].
    Komarov FI; Ol'binskaia LI; Vartanova OA; Bragina GI; Ovchinnikova LV
    Klin Med (Mosk); 1980 Aug; 58(8):55-60. PubMed ID: 6774161
    [No Abstract]   [Full Text] [Related]  

  • 30. Discordance of anti-ischemic and hemodynamic effects of captopril in stable coronary artery disease.
    Winkelmann BR; Matheis G; Kleist P; Pötter S; Wohltmann D; Kaltenbach M
    Coron Artery Dis; 1994 Oct; 5(10):829-44. PubMed ID: 7866603
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Short- and long-term effects of molsidomine retard and molsidomine nonretard on exercise capacity and clinical status in patients with stable angina: a multicenter randomized double-blind crossover placebo-controlled trial.
    Messin R; Karpov Y; Baikova N; Bruhwyler J; Monseu MJ; Guns C; Géczy J
    J Cardiovasc Pharmacol; 1998 Feb; 31(2):271-6. PubMed ID: 9475269
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Acute and chronic effect of molsidomine extended release on exercise capacity in patients with stable angina, a double-blind cross-over clinical trial versus placebo.
    Messin R; Boxho G; De Smedt J; Buntinx IM
    J Cardiovasc Pharmacol; 1995 Apr; 25(4):558-63. PubMed ID: 7596123
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Long-term effects of molsidomine on exercise tolerance in patients with exertional angina pectoris.
    Kinoshita M; Sawamura M; Motomura M; Takayama Y; Kawaguchi Y; Kawakita S
    Jpn Circ J; 1983 Dec; 47(12):1398-405. PubMed ID: 6689183
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Influence of molsidomine on exercise-ECG'S In coronary insufficiency (author's transl)].
    Grewe N; Stauch M
    Dtsch Med Wochenschr; 1977 Dec; 102(48):1758-63. PubMed ID: 923459
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hemodynamic and coronary effects of molsidomine at basal state, during atrial pacing, and during cold pressor test in patients with stable angina pectoris.
    Juliard JM; Neukirch F; Zygelman M; Merillon JP; Michel PL; Pansard Y; Dahan M; Gourgon R
    Am Heart J; 1985 Mar; 109(3 Pt 2):662-6. PubMed ID: 3838404
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Short-term hemodynamic, anti-ischemic, and antianginal effects of pirsidomine, a new sydnonimine.
    Stengele E; Ruf G; Jähnchen E; Trenk D; Löffler K; Schulz W; Roskamm H
    Am J Cardiol; 1996 May; 77(11):937-41. PubMed ID: 8644642
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Differences in the antiischaemic effects of molsidomine and isosorbide dinitrate (ISDN) during acute and short-term administration in stable angina pectoris.
    Wagner F; Gohlke-Bärwolf C; Trenk D; Jähnchen E; Roskamm H
    Eur Heart J; 1991 Sep; 12(9):994-9. PubMed ID: 1936012
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [The classic anti-anginal agents and molsidomine].
    Vacheron A
    Arch Mal Coeur Vaiss; 1983 Feb; 76 Spec No():71-5. PubMed ID: 6407452
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Molsidomine in exertion angina].
    Witchitz S; Kolsky H; Moisson P
    Ann Cardiol Angeiol (Paris); 1983 Dec; 32(8):539-43. PubMed ID: 6689396
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Pharmacological basis of therapy with molsidomine].
    Bassenge E
    Herz; 1982 Oct; 7(5):296-306. PubMed ID: 6897544
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.